Diagnosis and treatment of Budd-Chiari syndrome accompanied with hepatic nodules
10.3760/cma.j.cn113884-20200309-00126
- VernacularTitle:布加综合征合并肝脏结节的诊治体会
- Author:
Yaoxuan WANG
;
Qingfeng JIANG
;
Ke LI
;
Huanzhou XUE
;
Yuwei TIAN
;
Jiajia WANG
- From:
Chinese Journal of Hepatobiliary Surgery
2021;27(1):52-54
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize our experience in diagnosis and treatment of Budd-Chiari syndrome(BCS) accompanied with hepatic nodules.Methods:The clinical data of 33 patients with BCS accompanied with hepatic nodules who were treated at Henan Provincial People's Hospital from January 2012 to December 2018 were retrospectively analysed. A total of 33 patients were enrolled, including 17 males and 16 females, with an average age of 51 years. Analyze the treatment and prognosis of different types of nodules.Results:Of 33 patients, 27 were diagnosed to have hepatocellular carcinoma and 6 benign proliferative nodules. Treatment of patients with hepatocellular carcinoma included, transcatheter arterial chemoembolization ( n=1) and hepatectomy ( n=26). The survival time of these patients with hepatocellular carcinoma ranged from 10.0 to 78.0 months (mean 37.8 months). For the remaining 6 patients with benign nodules, the nodules were multiple and no malignant changes were observed on follow-up. Conclusion:For patients with BCS associated with benign nodules, no specific treatment was required. Hepatocellular carcinoma assocated with BCS had good prognosis. An aggressive surgical resectional approach is recommended to treat and to relieve the hepatic outflow obstruction.
